CN105770818A - Traditional Chinese medicine composition for treating uterine fibroid - Google Patents
Traditional Chinese medicine composition for treating uterine fibroid Download PDFInfo
- Publication number
- CN105770818A CN105770818A CN201610222922.6A CN201610222922A CN105770818A CN 105770818 A CN105770818 A CN 105770818A CN 201610222922 A CN201610222922 A CN 201610222922A CN 105770818 A CN105770818 A CN 105770818A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/264—Aristolochia (Dutchman's pipe)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating uterine fibroid. The traditional Chinese medicine composition is prepared from, by weight, 10-30 parts of radix arnebiae/radix lithospermi, 5-25 parts of herba menthae, 5-20 parts of pseudobulb of appendiculate cremastra, 5-25 parts of rhizoma curcumae, 5-25 parts of radix dipsaci, 5-25 parts of carapax testudinis, 5-20 parts of donkey-hide glue, 5-25 parts of Chinese sage herbs, 5-20 parts of radix rubiae, 5-25 parts of rrst-coloured crotalaria herbs, 5-20 parts of herba aristolochiae, 5-25 parts of radix scrophulariae, 5-25 parts of flos rosae chinensis, 5-25 parts of radix ranunculi ternate, 5-20 parts of flos campsis, 5-25 parts of herba selaginellae, 5-25 parts of livistona chinensis (Jacq.)R.Br., 5-25 parts of fructus corni, 5-20 parts of medulla junci, 5-25 parts of ginger processed pinellia, 5-25 parts of squama manis, 5-20 parts of common ginger 5-25 parts of radix semiaquilegiae and 5-15 parts of radix glycyrrhizae. The traditional Chinese medicine composition has the effects of soothing liver-qi stagnation, clearing away heat and toxic materials, eliminating dampness and eliminating phlegm, replenishing blood and tonifying qi, promoting blood circulation to remove blood stasis and softening hardness to dissipate stagnation and is remarkable in curative effect on treatment of uterine fibroid and reliable in function.
Description
Technical field
The present invention relates to the pharmaceutical product not determining structure of a kind of traditional herbal medicines, a kind of Chinese medicine composition treating hysteromyoma.
Background technology
Hysteromyoma is the modal tumors of female sex organs, is also the modal tumor of human body, is mainly formed by smooth muscle cell proliferation, has a small amount of fibrous connective tissue therebetween, is common in 30-50 year women.According to statistics, the women of child-bearing age of at least 20% have hysteromyoma.Most hysteromyoma are optimum.But owing to hysteromyoma tends to multiple, therefore, at Women of childbearing age, with age, muscular tumor may be gradually increased and increase, myomectomy operation is the most likely recurred.Its modal clinical symptoms is: metrorrhagia, hypogastralgia and dysmenorrhea, pressure symptom, vaginal secretions increase, anemia, even cause infertile, severely impact the healthy of women and daily life works, as treated not in time, it is possible to be changed into malignant tumor.At present, modern medicine uses the method treatment hysteromyoma such as operation or hormone interference.The medicine for the treatment of hysteromyoma is mainly Western medicine.But; reduce though the hysteromyoma after said medicine is treated has; but the impact of female normal physiological function relatively greatly and had certain side effect; inside of human body normal hormone secretion level would generally be affected; destroy human normal physiological equilibrium; manlike feature in various degree occur, after drug withdrawal, muscular tumor grows again, is finally difficult to thoroughly be effected a radical cure.Therefore Western medicine have that weak curative effect, side effect be big, the easy weak point such as recurrence after treatment.
Motherland's medical science think hysteromyoma many lose bar because of internal injury caused by excess of seven emotions, liver and reach, the retardance of visceral dysfunction, mechanism of qi, stop in blood stasis, gas gathers and for abdominal mass, blood agglomeration is, or stagnation of phlegm-damp punching appoint a vessels of the uterus, the expectorant stasis of blood fight knot, gradually amass into, or wet accumulate heat-transformation, or sense toxic dampness and heat and blood fight knot, stagnation of blood stasis in CHONG and REN meridians, tie and form abdominal mass in vessels of the uterus.
According to theory of Chinese medical science, for the pathogeny of hysteromyoma, use dispersing the stagnated live-QI to relieve the stagnation of QI, heat-clearing and toxic substances removing, drying dampness to eliminate phlegm, blood yiqi, blood circulation promoting and blood stasis dispelling, the method for the treatment of of hard masses softening and resolving, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome in prior art treat hysteromyoma exist deficiency, the present invention provide a kind of prepare simplicity, low cost, evident in efficacy, have no side effect treatment hysteromyoma Chinese medicine composition.
nullThe technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition treating hysteromyoma,It is characterized in that: its raw material of Chinese medicine and weight be: Radix Arnebiae (Radix Lithospermi) 10-30 part、Herba Menthae 5-25 part、Pseudobulbus Cremastrae Seu Pleiones 5-20 part、Rhizoma Curcumae 5-25 part、Radix Dipsaci 5-25 part、Carapax et Plastrum Testudinis 5-25 part、Colla Corii Asini 5-20 part、Herba Salviae Chinensis 5-25 part、Radix Rubiae 5-25 part、Herba Crotalariae Ferrugineae 5-25 part、Herba Aristolochiae 5-20 part、Radix Scrophulariae 5-25 part、Flos Rosae Chinensis 5-25 part、Radix Ranunculi Ternati 5-25 part、Flos Campsis 5-20 part、Herba Selaginellae 5-25 part、Chinese fanpalm seed 5-25 part、Fructus Corni 5-25 part、Medulla Junci 5-20 part、Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 5-25 part、Squama Manis 5-25 part、Rhizoma Zingiberis Preparatum 5-20 part、Radix Semiaquilegiae 5-25 part、Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition treating hysteromyoma, it is characterized in that: its raw material of Chinese medicine and weight be: Radix Arnebiae (Radix Lithospermi) 20 parts, Herba Menthae 15 parts, Pseudobulbus Cremastrae Seu Pleiones 10 parts, Rhizoma Curcumae 15 parts, Radix Dipsaci 15 parts, Carapax et Plastrum Testudinis 15 parts, 10 parts of Colla Corii Asini, Herba Salviae Chinensis 15 parts, 15 parts of Radix Rubiae, Herba Crotalariae Ferrugineae 15 parts, Herba Aristolochiae 10 parts, Radix Scrophulariae 15 parts, Flos Rosae Chinensis 15 parts, Radix Ranunculi Ternati 15 parts, Flos Campsis 10 parts, Herba Selaginellae 15 parts, Chinese fanpalm seed 15 parts, Fructus Corni 15 parts, Medulla Junci 10 parts, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15 parts, Squama Manis 15 parts, Rhizoma Zingiberis Preparatum 10 parts, Radix Semiaquilegiae 15 parts, 10 parts of Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Radix Arnebiae (Radix Lithospermi) has clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, effect of removing toxic substances rash;Herba Menthae has dispelling wind and heat pathogens, clear profit removing toxic substances, effect of dispersing the stagnated live-QI to relieve the stagnation of QI;Pseudobulbus Cremastrae Seu Pleiones has effect of heat-clearing and toxic substances removing, dissipating phlegm and resolving masses;Rhizoma Curcumae has circulation of qi promoting removing blood stasis, effect of removing food stagnancy pain relieving;Radix Dipsaci has invigorating the liver and kidney, reuniting the fractured tendons and bones, effect of promoting the circulation of blood arteries and veins;Carapax et Plastrum Testudinis has nourishing kidney YANG hyperactivity suppressing, replenishing kidney and strengthening bone, the effect of reinforcing the heart of nourishing blood;Colla Corii Asini has nourshing Yin and drynsessmoistening prescription, effect of blood yiqi, arresting bleeding and miscarriage prevention;Herba Salviae Chinensis has effect of heat-clearing and toxic substances removing, invigorating blood circulation analgesia;Effect that Radix Rubiae has cooling blood for hemostasis, blood stasis dispelling is stimulated the menstrual flow;Herba Crotalariae Ferrugineae has nourishing the kidney and liver、Relieving cough and asthma、Effect of eliminating damp, detoxifying;Herba Aristolochiae has circulation of qi promoting removing dampness、Effect of promoting blood circulation and stopping pain;Radix Scrophulariae has effect of removing heat from blood YIN nourishing, eliminating fire and detoxication;Flos Rosae Chinensis has effect of promoting blood flow to regulate menstruation, removing toxic substances and promoting subsidence of swelling;Radix Ranunculi Ternati has effect of mass dissipating and swelling eliminating;Flos Campsis has effect of clearing away heat and cooling blood, blood stasis-eliminating and stagnation-dissipating, dispelling wind for relieving itching;Herba Selaginellae has reinforcing YIN-essence benefit essence, effect of promoting blood circulation to restore menstrual flow;Chinese fanpalm seed has effect of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving;Fructus Corni has effect of liver and kidney tonifying, essence astringing and desertion stemming;Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) has drying dampness to eliminate phlegm、Effect of stopping nausea and vomiting by lowering the adverse flow of QI;Medulla Junci has effect of relieving stranguria by diuresis, clearing heart fire;Squama Manis has effect of promoting blood circulation to remove obstruction in the collateral, detumescence and apocenosis, wind-expelling pain-stopping, lactogenesis;Rhizoma Zingiberis Preparatum has effect of warming spleen and stomach for dispelling cold, warming the meridian for stopping bleeding;Radix Semiaquilegiae has effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, relieving stranguria by diuresis;Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component, through dialectical compatibility, helps using mutually assistant, plays effect of dispersing the stagnated live-QI to relieve the stagnation of QI, heat-clearing and toxic substances removing, drying dampness to eliminate phlegm, blood yiqi, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving altogether, and the treatment to hysteromyoma reaches treating both the principal and secondary aspects of a disease.
The component of the present composition all uses natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, low cost.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug use the use that is decocted in water for oral dose.Verifying by clinic application, it is evident in efficacy reliably, mild in medicine property and, do not occur that toxic and side effects, effective percentage reach 95%, cure rate 76.6%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Arnebiae (Radix Lithospermi) 20g, Herba Menthae 15g, Pseudobulbus Cremastrae Seu Pleiones 10g, Rhizoma Curcumae 15g, Radix Dipsaci 15g, Carapax et Plastrum Testudinis 15g, Colla Corii Asini 10g, Herba Salviae Chinensis 15g, Radix Rubiae 15g, Herba Crotalariae Ferrugineae 15g, Herba Aristolochiae 10g, Radix Scrophulariae 15g, Flos Rosae Chinensis 15g, Radix Ranunculi Ternati 15g, Flos Campsis 10g, Herba Selaginellae 15g, Chinese fanpalm seed 15g, Fructus Corni 15g, Medulla Junci 10g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15g, Squama Manis 15g, Rhizoma Zingiberis Preparatum 10g, Radix Semiaquilegiae 15g, Radix Glycyrrhizae 10g.
Embodiment 2
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Arnebiae (Radix Lithospermi) 15g, Herba Menthae 25g, Pseudobulbus Cremastrae Seu Pleiones 12g, Rhizoma Curcumae 20g, Radix Dipsaci 5g, Carapax et Plastrum Testudinis 25g, Colla Corii Asini 12g, Herba Salviae Chinensis 20g, Radix Rubiae 5g, Herba Crotalariae Ferrugineae 25g, Herba Aristolochiae 12g, Radix Scrophulariae 20g, Flos Rosae Chinensis 5g, Radix Ranunculi Ternati 25g, Flos Campsis 12g, Herba Selaginellae 20g, Chinese fanpalm seed 5g, Fructus Corni 25g, Medulla Junci 12g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 20g, Squama Manis 5g, Rhizoma Zingiberis Preparatum 15g, Radix Semiaquilegiae 10g, Radix Glycyrrhizae 15g.
Embodiment 3
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Arnebiae (Radix Lithospermi) 25g, Herba Menthae 5g, Pseudobulbus Cremastrae Seu Pleiones 15g, Rhizoma Curcumae 10g, Radix Dipsaci 20g, Carapax et Plastrum Testudinis 5g, Colla Corii Asini 15g, Herba Salviae Chinensis 10g, Radix Rubiae 20g, Herba Crotalariae Ferrugineae 5g, Herba Aristolochiae 15g, Radix Scrophulariae 10g, Flos Rosae Chinensis 20g, Radix Ranunculi Ternati 5g, Flos Campsis 15g, Herba Selaginellae 10g, Chinese fanpalm seed 20g, Fructus Corni 5g, Medulla Junci 20g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 10g, Squama Manis 25g, Rhizoma Zingiberis Preparatum 5g, Radix Semiaquilegiae 20g, Radix Glycyrrhizae 8g.
Embodiment 4
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Arnebiae (Radix Lithospermi) 10g, Herba Menthae 20g, Pseudobulbus Cremastrae Seu Pleiones 5g, Rhizoma Curcumae 25g, Radix Dipsaci 10g, Carapax et Plastrum Testudinis 20g, Colla Corii Asini 5g, Herba Salviae Chinensis 25g, Radix Rubiae 10g, Herba Crotalariae Ferrugineae 20g, Herba Aristolochiae 5g, Radix Scrophulariae 25g, Flos Rosae Chinensis 10g, Radix Ranunculi Ternati 20g, Flos Campsis 5g, Herba Selaginellae 25g, Chinese fanpalm seed 10g, Fructus Corni 20g, Medulla Junci 5g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 25g, Squama Manis 10g, Rhizoma Zingiberis Preparatum 20g, Radix Semiaquilegiae 5g, Radix Glycyrrhizae 15g.
Embodiment 5
A kind of Chinese medicine composition treating hysteromyoma, its raw material of Chinese medicine and weight proportion be: Radix Arnebiae (Radix Lithospermi) 30g, Herba Menthae 10g, Pseudobulbus Cremastrae Seu Pleiones 20g, Rhizoma Curcumae 5g, Radix Dipsaci 25g, Carapax et Plastrum Testudinis 10g, Colla Corii Asini 20g, Herba Salviae Chinensis 5g, Radix Rubiae 25g, Herba Crotalariae Ferrugineae 10g, Herba Aristolochiae 20g, Radix Scrophulariae 5g, Flos Rosae Chinensis 25g, Radix Ranunculi Ternati 10g, Flos Campsis 20g, Herba Selaginellae 5g, Chinese fanpalm seed 25g, Fructus Corni 10g, Medulla Junci 15g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 5g, Squama Manis 20g, Rhizoma Zingiberis Preparatum 12g, Radix Semiaquilegiae 25g, Radix Glycyrrhizae 5g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: put in container by the raw material of Chinese medicine of prescription, adds cold water and covers powder, soak 15~20 minutes, added water no powder about 6 centimetres, carries out decocting for the first time, at a simmer before use intense fire to decoct, with slow fire boiling 20~30 minutes after boiling;Second time decocts, and added water no powder about 4 centimetres, decocts 15~20 minutes after water boiling.Decoct extracting juice twice, merge.
The present invention, with a kind of Chinese medicine composition treating hysteromyoma given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 60 example, age 30~50 years old.
Two, diagnosis basis:
(1) menorrhagia, menostaxis or irregular bleeding, lower abdomen may occur in which that lump, minority have pain and pressure symptom, or companion's anemia;
(2) uterus increases, and matter is hard;
(3) detection uterine cavity increases or deformation;
(4) examine and when scraping, in uterine cavity, touch crowning;
(5) B is super and/or uteroscopy can assist to check.
Three, usage and dosage: during clinical practice, potion on the one, decocting twice extracting juice about 400ml, point morning, twice empty stomach decoction being taken warmly in evening.It within five days, it is a course for the treatment of.Avoid cold and uncooked food during treatment the thing of pungent stimulation.
Four, criterion of therapeutical effect:
1, recovery from illness: clinical symptoms all disappears, B is super checks that hysteromyoma disappears;
2, effective: clinical symptom relief, B is super checks that hysteromyoma diameter diminishes or not regrowth;
3, invalid: clinical symptoms is without being clearly better or increasing the weight of, and B is super checks that hysteromyoma continues to grow up.
Five, therapeutic effect: in this clinical observation case, take medicine 5-10 the course for the treatment of, 46 examples of fully recovering, follow up a case by regular visits to have no recurrence;Effective 11 examples, invalid 3 examples.Toxic and side effects is there is not during treatment.
Six, model case:
Case 1:
Chapter, 34 years old.Suffer from hysteromyoma, irregular menses, the most irregularly, accompany lower abdominal distention pain, premenstrual mammary swelling.Taking 5 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, hysteromyoma disappears, and menstruation recovery is normal, cures.Follow up a case by regular visits to 1 year without recurrence.
Case 2:
Field, 47 years old.The most over the past half year, delayed period, few through row amount, color purple is dim, and through row abdomen pain less, light red tongue, tongue is micro-the most greasy, deep and hesitant pulse.The super display of B: anterior uterine wall is shown in 3.5cm × 2.9cm
Echo light blob.It is diagnosed as: hysteromyoma.Taking 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, B super display hysteromyoma reduces;Continuing to take 4 courses for the treatment of, hysteromyoma disappears, and menstruation recovery is normal.
Claims (2)
1. the Chinese medicine composition treating hysteromyoma, it is characterized in that: its raw material of Chinese medicine and weight be: Radix Arnebiae (Radix Lithospermi) 10-30 part, Herba Menthae 5-25 part, Pseudobulbus Cremastrae Seu Pleiones 5-20 part, Rhizoma Curcumae 5-25 part, Radix Dipsaci 5-25 part, Carapax et Plastrum Testudinis 5-25 part, Colla Corii Asini 5-20 part, Herba Salviae Chinensis 5-25 part, Radix Rubiae 5-25 part, Herba Crotalariae Ferrugineae 5-25 part, Herba Aristolochiae 5-20 part, Radix Scrophulariae 5-25 part, Flos Rosae Chinensis 5-25 part, Radix Ranunculi Ternati 5-25 part, Flos Campsis 5-20 part, Herba Selaginellae 5-25 part, Chinese fanpalm seed 5-25 part, Fructus Corni 5-25 part, Medulla Junci 5-20 part, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 5-25 part, Squama Manis 5-25 part, Rhizoma Zingiberis Preparatum 5-20 part, Radix Semiaquilegiae 5-25 part, Radix Glycyrrhizae 5-15 part.
A kind of Chinese medicine composition treating hysteromyoma, it is characterized in that: its raw material of Chinese medicine and weight be: Radix Arnebiae (Radix Lithospermi) 20 parts, Herba Menthae 15 parts, Pseudobulbus Cremastrae Seu Pleiones 10 parts, Rhizoma Curcumae 15 parts, Radix Dipsaci 15 parts, Carapax et Plastrum Testudinis 15 parts, 10 parts of Colla Corii Asini, Herba Salviae Chinensis 15 parts, 15 parts of Radix Rubiae, Herba Crotalariae Ferrugineae 15 parts, Herba Aristolochiae 10 parts, Radix Scrophulariae 15 parts, Flos Rosae Chinensis 15 parts, Radix Ranunculi Ternati 15 parts, Flos Campsis 10 parts, Herba Selaginellae 15 parts, Chinese fanpalm seed 15 parts, Fructus Corni 15 parts, Medulla Junci 10 parts, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15 parts, Squama Manis 15 parts, Rhizoma Zingiberis Preparatum 10 parts, Radix Semiaquilegiae 15 parts, 10 parts of Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610222922.6A CN105770818A (en) | 2016-04-12 | 2016-04-12 | Traditional Chinese medicine composition for treating uterine fibroid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610222922.6A CN105770818A (en) | 2016-04-12 | 2016-04-12 | Traditional Chinese medicine composition for treating uterine fibroid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105770818A true CN105770818A (en) | 2016-07-20 |
Family
ID=56395220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610222922.6A Pending CN105770818A (en) | 2016-04-12 | 2016-04-12 | Traditional Chinese medicine composition for treating uterine fibroid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105770818A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101549141A (en) * | 2008-04-03 | 2009-10-07 | 向朝晖 | Traditional Chinese medicine for treating hysteromyoma and metrocystosis and preparation process thereof |
CN103356969A (en) * | 2013-07-26 | 2013-10-23 | 黄淑娟 | Traditional Chinese medicine composition for treating hysteromyoma |
CN104857478A (en) * | 2015-05-25 | 2015-08-26 | 滨州医学院 | Medical composition for treating hysteromyoma and preparation method of medical composition |
-
2016
- 2016-04-12 CN CN201610222922.6A patent/CN105770818A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101549141A (en) * | 2008-04-03 | 2009-10-07 | 向朝晖 | Traditional Chinese medicine for treating hysteromyoma and metrocystosis and preparation process thereof |
CN103356969A (en) * | 2013-07-26 | 2013-10-23 | 黄淑娟 | Traditional Chinese medicine composition for treating hysteromyoma |
CN104857478A (en) * | 2015-05-25 | 2015-08-26 | 滨州医学院 | Medical composition for treating hysteromyoma and preparation method of medical composition |
Non-Patent Citations (1)
Title |
---|
朱士伏: "芪胶莪蛭丸治疗子宫肌瘤30例", 《甘肃中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
CN104173565B (en) | A kind of Chinese medicine composition treating menoxenia | |
CN103212020B (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
CN105770294A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
CN104857463A (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
CN104306872A (en) | Traditional Chinese medicine for treating uterine fibroid | |
CN104606624A (en) | Traditional-Chinese-medicine composition for treating dampness and heat of liver and gallbladder | |
CN105749166A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
CN105770818A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
CN103816493B (en) | A kind of Chinese medicine composition treating instability of kidney QI | |
CN105770374A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
CN103285360B (en) | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof | |
CN105688056A (en) | Drug for treating urinary calculi and preparation method thereof | |
CN105288332A (en) | Traditional Chinese medicine composition for treating cyesedema | |
CN105687909A (en) | Traditional Chinese medicine composition for treating dysuria | |
CN104689282A (en) | Traditional Chinese preparation for curing dysfunctional uterine bleeding and preparing method | |
CN105853782A (en) | Traditional Chinese medicinal composition for treating uterine prolapsed | |
CN105560994A (en) | Traditional Chinese medicine composition for treating prolapse of uterus | |
CN105770478A (en) | Traditional Chinese medicine composition for treating bladder cancer | |
CN105106913A (en) | Traditional Chinese medicine composition for treating spleen-kidney yang deficiency type chronic colitis | |
CN103751715A (en) | Traditional Chinese medicine composition for treating pelvic inflammation | |
CN105194577A (en) | Medicament for treating hyperplasia of mammary glands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160720 |